![Cortney Caudill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cortney Caudill
Keine laufenden Positionen mehr
Vermögen: 469 440 $ am 31.05.2026
Profil
Cortney Caudill formerly worked at SAMSUNG BIOLOGICS Co., Ltd., as Director-Business Development Technology, Genentech, Inc., as Principal, VaxGen, Inc., as Principal, Baxalta Schweiz AG, as Head-Drug Product External Manufacturing Network from 2014 to 2016, Spyre Therapeutics, Inc., as Chief Product Officer in 2023, and Halozyme Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2025 to 2026.
Ms. Caudill received her Masters Business Admin degree from Fordham University and undergraduate degree from The University of Texas at Austin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.03.2026 | 7.055 ( 0,01 % ) | 469 440 $ | 31.05.2026 |
Ehemalige bekannte Positionen von Cortney Caudill
| Unternehmen | Position | Ende |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Geschäftsführer | 30.06.2026 |
| SPYRE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.01.2023 |
Baxalta Schweiz AG | Corporate Officer/Principal | 01.02.2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Corporate Officer/Principal | - |
Ausbildung von Cortney Caudill
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes biologic products | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAMSUNG BIOLOGICS Co., Ltd.
 SAMSUNG BIOLOGICS Co., Ltd. BiotechnologyHealth Technology Provides biologics development and manufacturing solutions | Health Technology |
Baxalta Schweiz AG |
Wählen Sie MarketScreener 
